Tag: Telix Pharmaceuticals

Telix Pharmaceuticals announced its agreement to acquire RLS (USA) Inc, the only Joint Commission-accredited radiopharmacy network in the US, as part of a strategic move to expand its North American manufacturing and distribution capabilities. 

Telix Pharmaceuticals Limited has entered into an agreement to acquire radioisotope production technology firm ARTMS Inc, its advanced cyclotron-based isotope production platform, manufacturing plant, and stockpile of ultra-pure rare metals required for consumable target production.

Telix Pharmaceuticals Limited announced its agreement to acquire IsoTherapeutics Group, a specialty radiopharmaceutical development and bioconjugation firm headquartered in Angleton, Texas.

The Federal Government has announced $23 million in support for the $71.2 million Australian Precision Medicine Enterprise as part of the Modern Manufacturing Initiative's...

Telix Pharmaceuticals has completed a strategic manufacturing agreement with global radiopharmaceuticals manufacturer Global Medical Solutions (GMS) to manufacture and supply finished unit doses of...

Melbourne-based Telix Pharmaceuticals has announced a technology transfer and manufacturing agreement with Canada's Isologic Innovative Radiopharmaceuticals. Telix, which develops diagnostic and therapeutic products based on...

Telix Pharmaceuticals has announced the establishment of a wholly-owned operating subsidiary in Japan to support its Japanese clinical and radiopharmaceutical manufacturing activities. Telix Co-Founder and...

Melbourne-based biopharmaceutical company Telix Pharmaceuticals has announced a manufacturing partnership with JFE Engineering Corporation, a Japanese company with extensive expertise in the installation of...